AstralBio
Privately held biotechnology company focused on discovery and development of therapeutic medicines for cardiometabolic and immune-mediated diseases. The organization highlights experience in antibody development and the use of a machine learning–enabled platform to accelerate progression of novel therapeutics.
Industries
Biotechnology Research
Nr. of Employees
small (1-50)
Expertise Areas
- Antibody therapeutics
- Machine-learning-driven drug discovery
- Cardiometabolic disease therapeutics
- Immune-mediated disease therapeutics
Key Technologies
- Machine learning for drug discovery
- Antibody engineering
- Computational biology
- Preclinical translational research